ImmunityBio acquiring U.S. rights to Tokyo strain of BCG
ImmunityBio, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $7.24
+1.0% in 3d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
+1.0%
7d
-1.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS